Targeted metabolomics reveals the role of ginsenoside Rb1 in modulating inflammation and cellular senescence in sepsis-induced acute lung injury

Sepsis-induced acute lung injury (ALI) is a major clinical challenge, with limited treatment options and high mortality. Ginsenoside Rb1, a bioactive compound derived from ginseng, has shown promising anti-inflammatory and antioxidative effects. This study is the first to systematically investigate...

Full description

Saved in:
Bibliographic Details
Main Authors: Fushuang Zheng, Wei Wang, Linlin Gao, Zhiling Fu
Format: Article
Language:English
Published: Tsinghua University Press 2025-06-01
Series:Food Science and Human Wellness
Subjects:
Online Access:https://www.sciopen.com/article/10.26599/FSHW.2025.9250658
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849390925121323008
author Fushuang Zheng
Wei Wang
Linlin Gao
Zhiling Fu
author_facet Fushuang Zheng
Wei Wang
Linlin Gao
Zhiling Fu
author_sort Fushuang Zheng
collection DOAJ
description Sepsis-induced acute lung injury (ALI) is a major clinical challenge, with limited treatment options and high mortality. Ginsenoside Rb1, a bioactive compound derived from ginseng, has shown promising anti-inflammatory and antioxidative effects. This study is the first to systematically investigate the metabolites of ginsenoside Rb1, specifically F2 and CK, in the context of sepsis-induced ALI modeled by lipopolysaccharide (LPS) administration, a widely used preclinical approach to mimic key inflammatory features of clinical sepsis. Unlike other studies, which primarily focus on ginsenoside Rb1 itself, our research specifically emphasizes the role of its metabolites in this process. We demonstrated that ginsenoside Rb1 significantly improved lung histopathological damage, reduced inflammation, and inhibited cell apoptosis in a sepsis-induced ALI mouse model. Metabolomics and proteomics analyses revealed that Rb1 is metabolized into F2 and CK, which activate the AMP-activated protein kinase (AMPK)/Sirtuin 1 (SIRT1) signaling pathway. This activation promotes Forkhead Box O1 (FOXO1) deacetylation, inhibiting its cytoplasmic translocation and enhancing mitochondrial unfolded protein response (mtUPR) gene transcription. In vitro experiments confirmed that ginsenoside Rb1 protected alveolar type Ⅱ (AT2) cells from oxidative stress and senescence, while restoring mitochondrial function. Blocking the AMPK/SIRT1 pathway or silencing FOXO1 reversed these protective effects, highlighting their crucial roles in Rb1's mitigation of ALI. Our findings provide new insights into the molecular mechanisms by which ginsenoside Rb1 alleviates sepsis-induced ALI and offer a potential therapeutic approach for treating sepsis-related lung injuries.
format Article
id doaj-art-aa1b9543e3d644a3a1a994d653d2042e
institution Kabale University
issn 2097-0765
2213-4530
language English
publishDate 2025-06-01
publisher Tsinghua University Press
record_format Article
series Food Science and Human Wellness
spelling doaj-art-aa1b9543e3d644a3a1a994d653d2042e2025-08-20T03:41:15ZengTsinghua University PressFood Science and Human Wellness2097-07652213-45302025-06-01146925065810.26599/FSHW.2025.9250658Targeted metabolomics reveals the role of ginsenoside Rb1 in modulating inflammation and cellular senescence in sepsis-induced acute lung injuryFushuang Zheng0Wei Wang1Linlin Gao2Zhiling Fu3Department of Thoracic Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, ChinaDepartment of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang 110004, ChinaDepartment of Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, ChinaDepartment of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang 110004, ChinaSepsis-induced acute lung injury (ALI) is a major clinical challenge, with limited treatment options and high mortality. Ginsenoside Rb1, a bioactive compound derived from ginseng, has shown promising anti-inflammatory and antioxidative effects. This study is the first to systematically investigate the metabolites of ginsenoside Rb1, specifically F2 and CK, in the context of sepsis-induced ALI modeled by lipopolysaccharide (LPS) administration, a widely used preclinical approach to mimic key inflammatory features of clinical sepsis. Unlike other studies, which primarily focus on ginsenoside Rb1 itself, our research specifically emphasizes the role of its metabolites in this process. We demonstrated that ginsenoside Rb1 significantly improved lung histopathological damage, reduced inflammation, and inhibited cell apoptosis in a sepsis-induced ALI mouse model. Metabolomics and proteomics analyses revealed that Rb1 is metabolized into F2 and CK, which activate the AMP-activated protein kinase (AMPK)/Sirtuin 1 (SIRT1) signaling pathway. This activation promotes Forkhead Box O1 (FOXO1) deacetylation, inhibiting its cytoplasmic translocation and enhancing mitochondrial unfolded protein response (mtUPR) gene transcription. In vitro experiments confirmed that ginsenoside Rb1 protected alveolar type Ⅱ (AT2) cells from oxidative stress and senescence, while restoring mitochondrial function. Blocking the AMPK/SIRT1 pathway or silencing FOXO1 reversed these protective effects, highlighting their crucial roles in Rb1's mitigation of ALI. Our findings provide new insights into the molecular mechanisms by which ginsenoside Rb1 alleviates sepsis-induced ALI and offer a potential therapeutic approach for treating sepsis-related lung injuries.https://www.sciopen.com/article/10.26599/FSHW.2025.9250658sepsis-induced acute lung injuryginsenoside rb1ampk/sirt1 pathwayalveolar type ⅱ epithelial cells
spellingShingle Fushuang Zheng
Wei Wang
Linlin Gao
Zhiling Fu
Targeted metabolomics reveals the role of ginsenoside Rb1 in modulating inflammation and cellular senescence in sepsis-induced acute lung injury
Food Science and Human Wellness
sepsis-induced acute lung injury
ginsenoside rb1
ampk/sirt1 pathway
alveolar type ⅱ epithelial cells
title Targeted metabolomics reveals the role of ginsenoside Rb1 in modulating inflammation and cellular senescence in sepsis-induced acute lung injury
title_full Targeted metabolomics reveals the role of ginsenoside Rb1 in modulating inflammation and cellular senescence in sepsis-induced acute lung injury
title_fullStr Targeted metabolomics reveals the role of ginsenoside Rb1 in modulating inflammation and cellular senescence in sepsis-induced acute lung injury
title_full_unstemmed Targeted metabolomics reveals the role of ginsenoside Rb1 in modulating inflammation and cellular senescence in sepsis-induced acute lung injury
title_short Targeted metabolomics reveals the role of ginsenoside Rb1 in modulating inflammation and cellular senescence in sepsis-induced acute lung injury
title_sort targeted metabolomics reveals the role of ginsenoside rb1 in modulating inflammation and cellular senescence in sepsis induced acute lung injury
topic sepsis-induced acute lung injury
ginsenoside rb1
ampk/sirt1 pathway
alveolar type ⅱ epithelial cells
url https://www.sciopen.com/article/10.26599/FSHW.2025.9250658
work_keys_str_mv AT fushuangzheng targetedmetabolomicsrevealstheroleofginsenosiderb1inmodulatinginflammationandcellularsenescenceinsepsisinducedacutelunginjury
AT weiwang targetedmetabolomicsrevealstheroleofginsenosiderb1inmodulatinginflammationandcellularsenescenceinsepsisinducedacutelunginjury
AT linlingao targetedmetabolomicsrevealstheroleofginsenosiderb1inmodulatinginflammationandcellularsenescenceinsepsisinducedacutelunginjury
AT zhilingfu targetedmetabolomicsrevealstheroleofginsenosiderb1inmodulatinginflammationandcellularsenescenceinsepsisinducedacutelunginjury